App aims to keep minority cancer patients on Life-Extending drugs
NCT ID NCT05812274
Summary
This study tested a phone app and monitoring service designed to help minority patients with lung cancer better manage the side effects of their immunotherapy drugs. The goal was to help patients stay on their treatment longer and avoid unnecessary trips to the hospital. Researchers enrolled 30 patients to see if the app improved their care experience and treatment outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center
New York, New York, 10032, United States
-
Montefiore Health Center
New York, New York, 10029, United States
-
Mount Sinai School of Medicine
New York, New York, 10029, United States
-
NYU Medical Center
New York, New York, 10029, United States
Conditions
Explore the condition pages connected to this study.